Ghrelin Is a Novel Regulator of GLP-1 Secretion

GLP-1 is a gastrointestinal L-cell hormone that enhances glucose-stimulated insulin secretion. Hence, strategies that prevent GLP-1 degradation or activate the GLP-1 receptor are used to treat patients with type 2 diabetes. GLP-1 secretion occurs after a meal and is partly regulated by other circulating hormones. Ghrelin is a stomach-derived hormone that plays a key role in whole-body energy metabolism. Because ghrelin levels peak immediately before mealtimes, we hypothesized that ghrelin plays a role in priming the intestinal L-cell for nutrient-induced GLP-1 release. The intraperitoneal injection of ghrelin into mice 15 min before the administration of oral glucose enhanced glucose-stimulated GLP-1 release and improved glucose tolerance, whereas the ghrelin receptor antagonist D-Lys GHRP-6 reduced plasma levels of GLP-1 and insulin and diminished oral glucose tolerance. The ghrelin-mediated improvement in glucose tolerance was lost in mice coinjected with a GLP-1 receptor antagonist as well as in Glp1r−/− mice lacking the GLP-1 receptor. The impaired oral glucose tolerance in diet-induced obese mice was also improved by ghrelin preadministration. Importantly, ghrelin directly stimulated GLP-1 release from L-cell lines (murine GLUTag, human NCI-H716) through an extracellular signal–related kinase 1/2–dependent pathway. These studies demonstrate a novel role for ghrelin in enhancing the GLP-1 secretory response to ingested nutrients.

[1]  P. Brubaker,et al.  Circadian Secretion of the Intestinal Hormone GLP-1 by the Rodent L Cell , 2014, Diabetes.

[2]  J. Sowers,et al.  Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system. , 2014, American journal of physiology. Heart and circulatory physiology.

[3]  M. Tschöp,et al.  Acute Administration of Unacylated Ghrelin Has No Effect on Basal or Stimulated Insulin Secretion in Healthy Humans , 2014, Diabetes.

[4]  D. Parkes,et al.  Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  S. Dalle,et al.  GLP-1-based strategies: a physiological analysis of differential mode of action. , 2014, Physiology.

[6]  P. Brubaker,et al.  Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell , 2014, Diabetologia.

[7]  A. Schürmann,et al.  Minor Role of Mitochondrial Respiration for Fatty-Acid Induced Insulin Secretion , 2013, International journal of molecular sciences.

[8]  M. Serrano,et al.  Ghrelin requires p53 to stimulate lipid storage in fat and liver. , 2013, Endocrinology.

[9]  D. Drucker,et al.  Pharmacology, physiology, and mechanisms of incretin hormone action. , 2013, Cell metabolism.

[10]  Guoxiong Xu,et al.  The effect of ghrelin on cell proliferation in small intestinal IEC-6 cells. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  M. Kakei,et al.  Exogenous and endogenous ghrelin counteracts GLP‐1 action to stimulate cAMP signaling and insulin secretion in islet β‐cells , 2012, FEBS letters.

[12]  S. Yoshida,et al.  The therapeutic potential of GPR119 agonists for type 2 diabetes , 2012, Expert opinion on investigational drugs.

[13]  D. Drucker,et al.  Cardiovascular biology of the incretin system. , 2012, Endocrine reviews.

[14]  G. Camussi,et al.  The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways , 2012, Diabetologia.

[15]  Qinghua Wang,et al.  GABA Coordinates with Insulin in Regulating Secretory Function in Pancreatic INS-1 β-Cells , 2011, PloS one.

[16]  C. Ricordi,et al.  Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming human beta cell function , 2011, Nature Medicine.

[17]  S. Woods,et al.  Ghrelin‐induced adiposity is independent of orexigenic effects , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  M. Helder,et al.  Purification of a candidate gonadotrophin surge‐inhibiting/attenuating factor (GnSIF/AF) showing MAPK as a possible target , 2011, Molecular reproduction and development.

[19]  G. Radda,et al.  Synaptotagmin-7 as a positive regulator of glucose-induced glucagon-like peptide-1 secretion in mice , 2011, Diabetologia.

[20]  D. Drucker,et al.  Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice , 2011, Diabetologia.

[21]  N. Freemantle.  Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones? , 2010, BMJ : British Medical Journal.

[22]  T. Buchanan,et al.  Obese Adolescents Show Impaired Meal Responses of the Appetite‐Regulating Hormones Ghrelin and PYY , 2010, Obesity.

[23]  P. Brubaker.  Minireview: update on incretin biology: focus on glucagon-like peptide-1. , 2010, Endocrinology.

[24]  C. Beglinger,et al.  Role of fat hydrolysis in regulating glucagon-like Peptide-1 secretion. , 2010, The Journal of clinical endocrinology and metabolism.

[25]  T. Jin,et al.  The rho guanosine 5'-triphosphatase, cell division cycle 42, is required for insulin-induced actin remodeling and glucagon-like peptide-1 secretion in the intestinal endocrine L cell. , 2009, Endocrinology.

[26]  G. Frühbeck,et al.  Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes , 2009, International Journal of Obesity.

[27]  P. Brubaker,et al.  GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell , 2009, Diabetes.

[28]  D. Leroith,et al.  Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. , 2009, Endocrinology.

[29]  R. Seeley,et al.  Role of Central Nervous System Glucagon-Like Peptide-1 Receptors in Enteric Glucose Sensing , 2008, Diabetes.

[30]  K. Nakao,et al.  Effects of ghrelin administration on decreased growth hormone status in obese animals. , 2007, American journal of physiology. Endocrinology and metabolism.

[31]  D. Drucker.  The role of gut hormones in glucose homeostasis. , 2007, The Journal of clinical investigation.

[32]  K. Kangawa,et al.  [Structure and function of ghrelin]. , 2007, Seikagaku. The Journal of Japanese Biochemical Society.

[33]  R. Reimer.  Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases. , 2006, The Journal of endocrinology.

[34]  P. Pfluger,et al.  Ghrelin action in the brain controls adipocyte metabolism. , 2006, The Journal of clinical investigation.

[35]  Jean Martinez,et al.  Regulation of ERK1/2 activity by ghrelin‐activated growth hormone secretagogue receptor 1A involves a PLC/PKCɛ pathway , 2006 .

[36]  M. Monteiro,et al.  Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers , 2006, International Journal of Obesity.

[37]  S. Bloom,et al.  Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. , 2006, Gut.

[38]  Jean Martinez,et al.  Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway. , 2006, British journal of pharmacology.

[39]  M. Nauck,et al.  Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes , 2006, Diabetologia.

[40]  C. Ohlsson,et al.  Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice , 2005, Gut.

[41]  S. Hashiguchi,et al.  Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in beta-cells: implication in the glycemic control in rodents. , 2004, Diabetes.

[42]  Jens J. Holst,et al.  Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes , 2004, Regulatory Peptides.

[43]  P. Brubaker,et al.  Role of leptin in the regulation of glucagon-like peptide-1 secretion. , 2003, Diabetes.

[44]  F. Reimann,et al.  Glucose-sensing in glucagon-like peptide-1-secreting cells. , 2002, Diabetes.

[45]  R. Silvestre,et al.  Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. , 2002, European journal of endocrinology.

[46]  R. Batterham,et al.  Ghrelin causes hyperphagia and obesity in rats. , 2001, Diabetes.

[47]  B. Wisse,et al.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. , 2001, Diabetes.

[48]  E. Ravussin,et al.  Circulating ghrelin levels are decreased in human obesity. , 2001, Diabetes.

[49]  P. Brubaker,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Monounsaturated Fatty Acid Diets Improve Glycemic , 2022 .

[50]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[51]  P. Brubaker,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Role of the Vagus Nerve in Mediating Proximal Nutrient- Induced Glucagon-Like Peptide-1 Secretion* , 2022 .

[52]  D. Drucker,et al.  Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. , 1998, Diabetes.

[53]  A. Buchan,et al.  Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose. , 1998, Endocrinology.

[54]  V. Marks,et al.  Attenuated GLP-1 secretion in obesity: cause or consequence? , 1996, Gut.

[55]  D. Drucker,et al.  Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. , 1994, Molecular endocrinology.

[56]  J. Holst,et al.  Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. , 1993, The Journal of clinical investigation.

[57]  P. Brubaker.  Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. , 1991, Endocrinology.

[58]  R. Eaton,et al.  Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. , 1986, The Journal of clinical endocrinology and metabolism.